» Articles » PMID: 35643886

Nutrition As Therapy in Liver Disease

Overview
Journal Clin Ther
Specialty Pharmacology
Date 2022 Jun 1
PMID 35643886
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The importance of nutrition is often underrecognized in the routine clinical care of patients with chronic liver disease. Nutrition therapy plays a significant role in the management of alcohol-related liver disease and nonalcoholic fatty liver disease. In patients with cirrhosis from any etiology, malnutrition and sarcopenia are directly related to mortality, and nutritional interventions play an important role in the management of these patients. This review explores the role of nutritional intervention as adjuvant therapy across all chronic liver disease.

Methods: A narrative, qualitative systematic review was performed via searches of PubMed for nutritional aspects in the care of chronic liver disease.

Findings: Nutritional therapy plays a critical role in the management of chronic liver disease. In nonalcoholic fatty liver disease, specific macronutrient management can lead to weight loss and improved outcomes in these patients. In patients with alcohol-related liver disease, chronic cholestatic liver disease, and decompensated cirrhosis, caloric and protein intake plays a vital role improving outcomes in these patients. Micronutrient deficencies are also common in these patients and require supplementation to prevent other complications of malnutrition. Assessment and management of nutrition should accompany the typical care plan of patients with chronic liver disease.

Implications: This review of nutritional therapy in chronic liver disease highlights the current evidence-based and societal recommendations of macronutrient and micronutrient management across the spectrum of all chronic liver disease.

Citing Articles

Development and external validation of Global Leadership Initiative on Malnutrition-dictated nomograms predicting long-term mortality in hospitalized patients with cirrhosis.

Liu Q, He Y, Yang F, Guo G, Yang W, Wu L Sci Prog. 2025; 108(1):368504251320157.

PMID: 39967253 PMC: 11837080. DOI: 10.1177/00368504251320157.


Efficacy of different nutrition interventions on sarcopenia in patients with cirrhosis: a systematic review and network meta-analysis.

Sobhrakhshankhah E, Farahmand M, Hasan Rashedi M, Shahinfar H, Shab-Bidar S, Dinari S BMC Nutr. 2025; 11(1):39.

PMID: 39940017 PMC: 11817602. DOI: 10.1186/s40795-025-01028-y.


Global Leadership Initiative on Malnutrition-defined malnutrition coexisting with visceral adiposity predicted worse long-term all-cause mortality among inpatients with decompensated cirrhosis.

Wang H, Zhao T, Guo G, Yang W, Zhang X, Yang F Nutr Diabetes. 2024; 14(1):76.

PMID: 39333477 PMC: 11436742. DOI: 10.1038/s41387-024-00336-9.


Resting energy expenditure in patients with liver cirrhosis: Indirect calorimetry vs. predictive equations.

Wang W, Yang T, Li N, Luo Q, Qin T, Tian M Asia Pac J Clin Nutr. 2024; 33(4):545-553.

PMID: 39209364 PMC: 11389802. DOI: 10.6133/apjcn.202412_33(4).0009.


FGF21-dependent alleviation of cholestasis-induced liver fibrosis by sodium butyrate.

Yang J, Chen L, Zhao S, Du C, Fan Y, Liu H Front Pharmacol. 2024; 15:1422770.

PMID: 39040469 PMC: 11260614. DOI: 10.3389/fphar.2024.1422770.